Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
180 hedge funds and large institutions have $2.63B invested in Axonics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 75 increasing their positions, 51 reducing their positions, and 41 closing their positions.
47% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 51
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 187 → 180 (-7)
11% less capital invested
Capital invested by funds: $2.95B → $2.63B (-$324M)
15% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 41
42% less call options, than puts
Call options by funds: $6.23M | Put options by funds: $10.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$45.3M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$42.4M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$37.3M |
| 4 |
AC
Armistice Capital
New York
|
+$23.7M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$22.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$137M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$25.1M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$24.4M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$24.4M |
| 5 |
SC
Samlyn Capital
New York
|
-$15.4M |
AXNX Hedge Fund Activity: Q4 2021 in Review
180 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q4 2021, worth a combined $2.63B — down 11% from $2.95B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of AXNX and 35 opened new positions — a net loss of 6 holders — while 51 trimmed existing stakes and 75 added.
The largest buyer was Millennium Management, adding an estimated $45.3M. The largest seller was Fidelity Investments, cutting an estimated $137M.
- 180 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q4 2021, down from 187 in Q3 2021.
- Funds reported $2.63B of Axonics, Inc. Common Stock stock for Q4 2021, down 11% quarter-over-quarter.
- 35 funds opened new Axonics, Inc. Common Stock positions in Q4 2021 and 41 closed out, a net change of -6 holders.
- The largest Axonics, Inc. Common Stock buyer in Q4 2021 was Millennium Management, an estimated $45.3M added.
- The largest Axonics, Inc. Common Stock seller in Q4 2021 was Fidelity Investments, an estimated $137M sold.
Based on aggregated 13F filings for Q4 2021.